mk2 Biotechnologies, Wacker, TUM to jointly develop process for the large-scale production of antimicrobial peptide
mk2 Biotechnologies, Wacker and the Technical University of Munich (TUM) will participate in a joint project targeting the development, large-scale production and purification of antimicrobial peptides (AMPs) for diverse applications. The project will run for two years. The aim is to take the final steps in rolling out industrially suitable AMPs as a sustainable alternative […]
